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ABSTRACT:
Transcranial direct current stimulation (tDCS) is one type of neuromodulation, which is an emerging technology that
holds promise for the future studies on therapeutic and diagnosis applications in treatment of neurological and
psychiatric diseases. Epilepsy is one of the commonest neurological disorders, caused by an enhanced cortical
excitability favoring paroxysmal neuronal discharge. Cathodaldirect current stimulation (ctDCS) is a low-cost noninvasive portable neuro-stimulatory technique which can transiently decrease cortical excitability in humans. This
was invasively demonstrated to reduce epileptiform discharges in animals.
INTRODUCTION:
Epilepsy affects approximately 50 million people
worldwide, and 80% of them live in the developing
world [1, 2]. Epilepsy is a chronic disorder which not
only affects the patient but also the entire family. An
individual is diagnosed to have epilepsy if they have
two or more unprovoked seizures occurring greater
than 24 hours apart. Seizures are casued by abnormal
electrical activity in the brain and can present in a
variety of forms like tonic-clonic activity of one limb or
entire body, staring, eye blinking, sudden jerks, sudden
loss of tone leading to falls. They can also present as
an abnormal sensation perceived by the patient.
Patient can have preserved awareness, altered
awareness or even loss of consciousness during a
seizure. They are usually brief lasting one to two
minutes but some seizures can be prolonged. If the
seizure lasts more than ﬁve minutes, it is considered as
status epilepticus.During some seizures patients can
have bowel or bladder incontinence. Some individuals
continue to have frequent seizures despite optimal
treatment with anti-seizure drugs. However, more than
70 percent of patients who are treated achieve longterm remission or freedom from seizures, normally
within 5 years of diagnosis [2].
Approximately 60% of patients with epilepsy have
some form of focal epilepsy, and 35% of this cohort
have an unsatisfactory response to anticonvulsant
medications (AEDs) [3]. Surgical therapy for
intractable neocortical epilepsy (NE) remains
suboptimal and may produce neurologic deﬁcits not
predicted from pre-surgical evaluation—an especially
serious problem in children [4, 5]. Although presurgical imaging and electrophysiologic localization of
the epileptic focus continue to improve, up to 80% of
resections for non–temporal lobe epilepsy yield
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less than excellent outcomes [6]. The relatively
disappointing results with present surgical techniques
have led clinical study epileptologists to explore other
approaches to treating focal seizures, including
external electrical ﬁelds, local cortical stimulation with
implanted electrodes, and microinjection of AEDs [57].
Available pharmacological strategies for seizure relief
in patients with neocortical epilepsy can be ineffective,
and are associated with prominent side effects such as
psychological and behavioral changes. Up to 35%of
patients with neocortical epilepsy experience drugresistance. Furthermore, precise localization of the
seizure focus for surgical resection is often difﬁcult. A
particular challenge in the evaluation of intractable
neocortical epilepsy patients is that in about 30% of
extra-temporal epilepsy cases, brain MRI does not
identify a lesion[8].Therefore, a non-pharmacologic,
non-surgical method to treat neocortical epilepsy with
limited side effects, either in the hospital or home
setting, remains an unmet medical need.
Consequences of Epilepsy
A variety of treatment modalities are available in the
form of drugs, Ketogenic diet, Vagus nerve stimulation
(VNS), Responsiveneurostimulation (RNS) and
epilepsy surgery. These modalities enable the majority
of people with epilepsy (PWE) to control their seizures,
but in about 30-40% seizures persist inspite of different
treatment modalities [3]. In many countries, this
disorder is still shrouded in secrecy and patients prefer
not to reveal or discuss their condition [4].
Understanding the unique and complex impact of
epilepsy on a person's quality of life (QOL) is also
increasinglyrecognized as an important component of
clinical care [5],
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and research in this area will identify factors affecting
quality of life QOL and may lead to strategies that
improve the management of epilepsy.
Patients with epilepsy diagnosed in childhood could
have many schooling hours disrupted, if the frequency
of seizures were high and this could lead to low
educational achievement and thus a lower
employability potential. Occupational related stress
with assignment deadlines and criticisms by
supervisors can be stressful enough to trigger seizures
[7]. Moreover, seizure itself sometime causes
accidentsand injuries thus preventing sufferers from
driving and depriving them from many types of
employment opportunities. Employers usually do not
give jobs to persons with epilepsy if they are
experiencing seizures that interfere with job
performance [8].
Nonetheless, a vast majority of individuals with
epilepsy in many resource-poor regions do not receive
treatment [9, 10]. Seizure remission is possible with
appropriate use of anti-seizure drugs. Epileptic
patients who were treated withanti-seizure drugs had
signiﬁcantly better QOL than the untreated people [10].
Monotherapy has been recognized to be able to
control seizures adequately in about 50% of patients
with epilepsy and polytherapy is only necessary in the
minority of people with more severe seizures.
Untreated epilepsy is a critical public health issue, as
people with untreated epilepsy face potentially
devastating social consequences and poor health
outcomes. Due to stigma, many persons with epilepsy
have lower employment and education levels and
lower socioeconomic status. For example, children
with epilepsy who have a seizure at school may be
rejected, while adults may be barred from marriage or
employment [11-14]. Psychiatric diseases such as
depression and mood disorders have been reported to
be common among PWE and are important
determinants of QOL [15,16].
People with uncontrolled epilepsy have a fear of next
seizure and may take precautions and impose
restrictions to avoid of having seizures at inappropriate
times, public places or social events.
Therefore, the management of epilepsy should be
aimed at controlling seizures and improving patient's
community life. Public educational programs should be
conducted in order to raise awareness of the general
public regarding the existence of effective therapy and
eliminate the stigma of epilepsy.

depends on an accurate diagnosis, making sure that a
person has epilepsy and knowing what kind is a critical
ﬁrst step. The diagnosis of epilepsy requires a
thorough history about the semiology of the event and
is aided by electroencephalography (EEG).
EEG has an important role in the diagnosis and
classiﬁcation of epilepsy. It can also provide
information for predicting the response to anti-seizure
drugs and to identify the surgically remediable
epilepsies.It can give a lot of information about where
the seizure is originating and how it is propagating in
the brain.
EEG is an important test for diagnosing epilepsy
because it records the electrical activity of the brain. It
is safe and painless. The abnormal waveforms include
spikes, sharp waves, and spike-and-wave discharges.
Spikes, sharp waves along with slow waves in a
speciﬁc area of the brain, such as the left temporal
lobe, indicate that focal seizures might possibly come
from that area. Primary generalized epilepsy, on the
other hand, is suggested by spike-and-wave
discharges that are widely spread over both
hemispheres of the brain, especially if they begin in
both hemispheres at the same time.
Unfortunately, EEG, although is the principal
diagnostic test for epilepsy diagnosis, is a passive
measure of cortical activity, and epileptiform
discharges are usually sporadic events. Consequently,
the sensitivity of a single EEG is only 29-55% [18-21],
and 8% of patients will never have interictal discharges
[22,23]. I would make sure these references are
accurate.
This turns out to be especially challenging when
bearing in mind epilepsy mimics such as psychogenic
non-epileptic seizures (PNES), cardiogenic syncope,
breath holding spells, stereotypies and recurrent
dystonias/tremors. PNES are caused by a
p sych o p a th o l o g i ca l p ro ce ss a n d co n si st o f
paroxysmal behavioral changes that resemble an
epileptic seizure but are not associated with
electrophysiological epileptic changes. They and are
primarily diagnosed by history and video-EEG.
Moreover, interictal discharges are seen in up to 12%
of patients without epilepsy [24,25].Therefore, in some
cases, an EEG may be carried out while you are asleep
(sleep EEG) or you may be given a small, portable
EEG recording device to monitor your brain activity
over 24 hours (ambulatory EEG).
Activating procedures like photic stimulation,
hyperventilation and sleep deprivation are used to
activate both interictal discharges and seizures. Photic
simulation is useful for activation of generalized
epileptiform discharges Hyperventilation is particularly
useful for primary generalized epilepsies; however, it
can also activate focal epileptiform discharges in up to
10% in partial epilepsies [27]. Several studies have
documented that sleep deprivation can increase the
chance of detecting epileptiform discharges in both
partial and generalized epilepsies [26]. This is mainly

DIAGNOSIS
Epilepsy is considered as fourth most prominent
neurological disorder in the world that can affect
people of all age groups. Exactly knowing if a person is
having an epileptic seizure and diagnosing the type of
seizure or epilepsy syndrome can sometime be
difﬁcult. And, since seizures rarely happen in a doctor's
ofﬁce, the information given to the doctor and other
health care professionals by you or other witnesses is
extremely important. Since the treatment of seizures
PAKISTAN JOURNAL OF NEUROLOGICAL SCIENCES
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due to the effect of sleep deprivation and not the sleep
per se. Activating procedures can increase the yield of
detecting interictal epileptiform discharges.
Thus, EEG can neither rule in nor rule out the diagnosis
in some situations. But still EEG is one of the most
important tools for diagnosis of epilepsy. It helps in
easy monitoring as well as proper management of
neurological disorders. However, the visual perception
of this complicated waveform analysis is not without
difference of opinions and demands highly skilled
interpreters for disease detection and diagnosis.
Hence, an automatic detection and monitoring
approach is desired in future perspectives. If
parameters and features of EEG signals are extracted
properly, then it can add great value in diagnosis
process and patients can be saved from severe harms
caused by sudden seizure attacks [29]. Accordingly,
epileptic cases frequently experience deferrals in
diagnosis and commencement of appropriate
management. On the other hand, normal physiological
discharges can be interpreted as epileptiform and the
patient is unnecessarily started on a seizure
medication.

making it optimal for blinding subjects (in shamcontrolled studies) by switching it off after the initial
sensory experience. A previous study demonstrated
that current densities 25 mA/cm2 did not damage brain
tissue and the protocols where 1-2 mA current is
administered fall within these limits [22]. Previous
studies have argued that in spite of a fraction of the
direct current being shunted through the scalp, tDCS
carries enough currents to the underlying cortex,
sufﬁcient for neuronal excitability shifts [23]. Another
study has also reported change in measures of
cerebral blood ﬂow in brain regions that are subjected
to transcranial anodal direct current thereby proving
that transcranially administered direct currents can
affect tissue excitability as well as regional blood ﬂow
as an indirect indicator of change in regional tissue
excitability [24].
The important properties that make tDCS
advantageous over other non-invasive brain
stimulation methods include its ease of use, its large
electrode size allowing inﬂuence over a larger neural
network, a sham mode allowing controlled
experiments and randomized controlled clinical trials,
and its portability making it possible to apply
stimulation while the patient receives
occupational/physical therapy. However, tDCS is
limited because of its poor temporal resolution and
anatomical localization. In addition, inter-individual
variation in conductivity due to differences in scalp,
hair, and bone composition can hamper the current
that is transmitted to the brain. Moreover, single
sessions and multi-day sessions have been done and
found to be safe [25]. tDCS is being used in the
epilepsy in different parts of the world.
Most of the studies use cathadoltDCS in 1 mA [21-25].
Most of the studies shows improvement in outcome
(e.g. decrease the epileptic discharge in active
groups). There is a defect in sample size, and we think
we should do multi-research in larger sample size due
to the huge improvement (e.g. Assenza G. 2014, only
two subjects and show huge improvement which is not
applicable. In general, tDCS is a good additional
treatment to epilepsy + medical therapy which is the
essential treatment until now.

EPILEPSY PREVALENCE:
In 2004, the world health organization (WHO)
estimated that nearly 80% of the burden of epilepsy
worldwide is borne by the resource-poor countries. In
developed countries, the lifetime prevalence rate for
epilepsy ranges from 3.5 to 10.7 per 1,000 personyears, and the incidence rate ranges from 24 to 53 per
100,000 person-years [18]. In recent systematic
reviews, the lifetime prevalence rates for active
epilepsy varied from 1.5 to 14 per 1,000 person-years
in Asia, from 5.1 to 57.0 per 1,000 person-years in Latin
America, and from 5.2 to 74.4 per 1,000 person-years
in sub-Saharan Africa [19]. In developing countries,
this ﬁgure is often close to twice as high due to the
higher risk of experiencing conditions that can lead to
permanent brain damage.
TRANSCRANIAL DIRECT CURRENT
STIMULATION (tDCS)
A constant current stimulator and surface electrodes
soaked in normal saline are required for tDCS. The
former is the source of steady ﬂow of 0-4 mA direct
current and it continually monitors the resistance in the
system. Saline soaked electrodes based onto the
scalp over desired areas [(e.g. the left or right
precentral gyrus region (corresponding to C3 or C4 of
the International 10-20 EEG system)] make terminal
relaying currents across the scalp and through the
underlying brain tissue. tDCS is a noninvasive brain
stimulation technique that induces polarity-dependent
(anodal electrode increase excitability and cathode
decrease excitability) alterations of cortical excitability.
Once turned on, the constant current stimulator
generates a transient tingling sensation under the
electrode which disappears in 30 sec to 1min thereby
PAKISTAN JOURNAL OF NEUROLOGICAL SCIENCES

ECONOMIC EFFECTS OF EPILEPSY
Economically, epilepsy has a huge effect, with almost
5% of the medical costs of industrialized countries
given to the disease. Although in real terms morbidity is
relatively low, the long-term impairments left behind
are hugely detrimental both in terms of hospital and
other care sector costs. In the past, the greatest
prevalence of epilepsy has been in the developed
countries, but a change in this pattern may be
expected as more and more countries adopt a more
Westernized way of life. The overall rate of epilepsy
incidence in low and middle income countries exceed
that than of high-income countries, by about 20%.
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CONCLUSIONS
Epilepsy is one of the leading causes of death and
neurological disability in adults, inﬂicting a heavy
burden on affected individuals and their families. tDCS
is a method for focal brain stimulation. tDCS is based
on decades-old observations that neuronal ﬁring is
modulated by low amplitude electrical direct current
(DC). Speciﬁcally, when applied to the cerebral cortex,
cathodal DC inhibits neuronal ﬁring [9, 10]. The
mechanisms by which cathodal DC reduces neuronal
ﬁring likely relate to hyper-polarization of the soma
membrane which occurs when the apical dendrites
neuron are oriented toward the cathode in a constant
electric ﬁeld. The practical application of tDCS is
simple: low amplitude DC is administered via scalp
electrodes such that the cerebral cortex is exposed to
cathodal DC beneath one of the electrodes, and the
return (anodal) electrodes can be placed anywhere
else on the body, or in more complex arrangements to
minimize currents at any site. tDCS methods have also
recently been adapted to rats for work with disease
models [11-14]. Hundreds of tDCS trials have
demonstrated the technique to be well tolerated and
safe. Direct electrical current stimulation is presently
FDA-approved for extracranial use, and FDA
applications for cranial stimulation (tDCS) for
management of mood disorder and chronic pain are in
progress. tDCS units are also inexpensive and lightweight. The electrical supply can be derived from
conventional 9-volt batteries. The scalp electrodes can
be fastened in seconds. tDCS can be combined easily
with other therapies, such as those that may be
required for resuscitation of an acutely-injured patient.
tDCS is presently under investigation as a treatment
for epilepsy, where excess cortical excitability is a
prominent feature of the disease process, and where
neuronal inhibition may be beneﬁcial. Thus for
e p i l e p s y, t D C S m a y o ff e r a p r a c t i c a l n o n pharmacologic therapy for the large minority,
approximately 35%, of patients whose seizure cannot
be controlled by medication.
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